A supplier change should leave a written trail from the old specification to the first affected batch. Agree who can approve the change, which evidence needs review and when the brand must be notified.
Decide which changes need prior approval
A purchasing agreement should distinguish a new label design from a change to the product that reaches the animal. A flavor with the same retail name may use a different carrier. A sachet with the same appearance may have a different contact layer. These examples need technical review before the buyer assumes equivalence. Create a change register that records the old and proposed material codes, the reason for the change and the intended first batch. Give the brand a defined opportunity to review changes that affect its specification or claims. Where the manufacturer concludes that no additional testing is needed, request the written basis. The contract should also explain what happens if the brand does not accept a proposed substitution. This avoids discovering an unresolved approval question after finished cartons have shipped.
Understand the food safety reanalysis trigger
For facilities subject to the relevant US preventive-controls requirements, 21 CFR 507.50 requires food safety plan reanalysis at least once every three years. It also identifies earlier triggers, including significant activity changes that create potential new hazards or increase existing hazards, and new hazard information. A preventive controls qualified individual must perform or oversee that reanalysis. This requirement is not a three-year permission to leave every product change unexamined. Confirm the facility’s applicability and the role of its food safety team. Keep that regulatory assessment distinct from the buyer’s review of performance, labeling and commercial specifications. A change may need contractual approval even when it does not trigger a revision to a food safety plan. Both decisions should have an identified owner and a retained record. eCFR: 21 CFR 507.50, reanalysis.
Connect the change to the batch and complaint record
The change register becomes useful when someone can identify which shipped units it affected. Record the effective date, first production batch, material lots and carton artwork revision. If old and new material remain in inventory, document how the manufacturer distinguishes them. Ask whether retained samples represent both versions and whether any stability or handling observations need follow-up. These records also help when a customer reports an unusual odor, a damaged seal or a film that behaves differently from an earlier order. A complaint investigation should start with the supplied lot and the approved specification for that lot. It should not assume that every product sold under the same brand name has identical materials. Before closing the change, confirm that the purchasing specification and the manufacturer’s working records agree.
Buyer checklist
- Identify proposed change and the reason for it.
- List affected specifications, claims, test methods and packaging documents.
- Record technical review, brand approval and release responsibility.
- Trace implementation to material lots, production batch and retained samples.
- Set a follow-up date when additional evidence remains outstanding.
Questions buyers ask
Does a new supplier always require a full repeat of development?
The review should be proportional to the actual difference and available evidence. Document which properties can be bridged and which need new assessment.
Is a certificate of analysis enough to approve a substitution?
A COA describes the tests it reports. It may not address sensory properties, film handling, packaging compatibility or the full supplier qualification question.
Who should approve the first changed batch?
The quality agreement should name the manufacturer’s release authority and any brand approval needed before shipment. Avoid relying on an informal sales message.
References and scope
Sources checked on 23 October 2026. This is supplier-authored development guidance, not an independent clinical review. Calculations marked as examples are not product test results. Questions or corrections: info@hytanbio.com.